ANTX
AN2 Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$121.12M
P/E Ratio
—
EPS
$-1.16
Beta
-1.32
52W High
$6.91
52W Low
$1.00
50-Day MA
$2.38
200-Day MA
$1.46
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About AN2 Therapeutics Inc
Anthem, Inc., is a health benefits company in the United States. The company is headquartered in Indianapolis, Indiana.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -52.10% |
| Return on Assets | -30.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.94 |
| Price-to-Book | 2.23 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -2.11 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $35.94M |
| Float | $16.96M |
| % Insiders | 19.89% |
| % Institutions | 51.46% |
Analyst Ratings
Consensus ($1.00 target)
1
HoldData last updated: 4/7/2026